Protherics raises L38.2 million to fund trio of deals

Cardiovascular, cancer and antibody company Protherics (LSE:PTI; PTIL) raised L38.2 million ($75.6 million) in a placing and open offer of 58.7 million shares at

Read the full 240 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE